Gordian Biotechnology

Drug Discovery · San Francisco, CA · Founded 2018 · Privately Held (backing)

Developer of a gene therapy discovery platform designed to improve research for complex diseases related to aging. Gordian Biotechnology is based in San Francisco, CA and was founded in 2018. It was valued at $170 million at its early-stage round in Dec 2021, the last priced event on record. It has raised $60 million across 1 recorded round; the latest was a $1.5 million seed round in Apr 2020.

PMV mark · valuation
$170.0M
Oct 2026
Priced at
its early-stage round
Dec 2021
Total raised
$60.0M
Last round
Seed Round
Apr 2020
What is Gordian Biotechnology worth?
$170.0MPrivateMarketView mark · Oct 2026

Valued at $170.0M at its early-stage round, Dec 2021. Nothing has traded since.

Free account
More of Gordian Biotechnology with a free account
  • ·The complete investor list: 32 names
  • ·Watch Gordian Biotechnology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Gordian Biotechnology funding history

1 rounds
DateRoundRaisedPost-money
Apr 2020Seed Round$1.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Gordian Biotechnology valuation

Gordian Biotechnology was valued at $170 million at its early-stage round in Dec 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Gordian Biotechnology raised?

Gordian Biotechnology has raised $60 million in total; 1 of its rounds is on record. The largest on record was a $1.5 million seed round in Apr 2020.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Cambrian Bio ($180 million), Claris Bio ($163 million) and Delix Therapeutics ($156 million).

How Gordian Biotechnology's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Gordian Biotechnology, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Gordian Biotechnology

What is Gordian Biotechnology worth?
Gordian Biotechnology is valued at $170.0M as of Oct 2026. Valued at $170.0M at its early-stage round, Dec 2021. Nothing has traded since.
How much has Gordian Biotechnology raised?
Gordian Biotechnology has raised $60.0M in total funding across 1 recorded rounds.
When did Gordian Biotechnology last raise?
Gordian Biotechnology last raised in Apr 2020 (Seed Round), raising $1.5M.